A Ketamine-assisted Group Therapy Intervention for Spanish-speaking Adults With Depression

Part of paid clinical trials in Chelsea, Massachusetts.

Sponsor
Juliana Zambrano, MD, MPH
Study ID
NCT06597695
Phase
PHASE1/PHASE2
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 64 Years
Healthy Volunteers
Not accepted

Interventions

  • Ketamine-assisted psychotherapy — DRUG
    Ketamine-assisted psychotherapy delivered in a group format

Study Details

This is a pilot clinical trial to assess the feasibility, safety, and preliminary efficacy of ketamine-assisted group therapy for Spanish-speaking adults with depression

Key Dates

Start date
Jul 23, 2025
Status verified
Jul 2025
Primary completion
Jul 1, 2026
Completion
Jul 1, 2026

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Open label
    Open label, single arm study

Primary Outcome Measure

Evaluate feasibility of a culturally adapted group-based ketamine intervention for Spanish- speaking adults with depression in a community setting [ Time Frame: 1 week post-intervention ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Massachusetts General Hospital, ChelseaChelseaMassachusetts02114
Juliana zambrano, MD, MPH
[email protected]
6177262000

Find similar trials in Chelsea, MA

By condition
Depression
By specialty
PsychiatryMental healthBehavioral health
By research site
Massachusetts General Hospital, Chelsea· Chelsea, MA

Related Studies